摘要:
Provided herein is a compound having the formula (I), (R2 is typically a tertiary nitrogen atom, being either alkyl-substituted or member of a heterocyclic ring; R7 is typically a monocyclic or bicyclic aromatic ring or a heterocyclic ring) wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT1B and 5HT1D antagonists.
摘要:
Compounds represented by general formula (1) and drugs containing the same, (wherein A represents optionally substituted phenyl, naphthyl, dihydronaphthyl, indenyl, pyridyl, indolyl, isoindolyl, quinolyl or isoquinolyl; X represents optionally substituted lower alkylene, etc.; Y represents a single bond, alkylene, etc.; Z represents -CH=CH-, -C C-, -(CH=CH)2-, -C C-CH=CH-, -CH=CH-C C-, etc.; and R represents hydrogen, lower alkyl, etc.). Because of their excellent IgE antibody production inhibitory effects, these compounds are useful as antiallergic agents, etc.
摘要:
The present invention is related to pyrrolidine oxadiazole and thiadiazole derivatives for use as pharmaceutically active compounds, as well as pharmaceutical formulations containing such pyrrolidine oxadiazole derivatives. Said pyrrolidine derivatives are useful in the treatment and/or prevention of preterm labor, premature birth and dysmenorrhea. In particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor. More preferably, said compounds are useful in the treatment and/or prevention of disease states mediated by oxytocin, including preterm labor, premature birth and dysmenorrhea. The present invention is furthermore related to novel pyrrolidine derivatives as well as to methods of their preparation. (I) B is a oxadiazole or thiadiazole group.
摘要:
Phenylalanine derivatives represented by general formula (1) or pharmaceutically acceptable salts thereof: wherein x represents an interatomic bond, -O-, etc.; Y and Z represent each -C(=O)-, etc.; A represents a specific substituted phenyl group, a specific nitrogen-containing heterocycle, etc.; C represents hydrogen, alkly, etc.; D and E represent each alkyl or D and E may be bonded to each other to form a ring, etc.; F and G represent each hydrogen or alkyl, or F and G may be bonded to each otherto form a ring, etc.; n is from 0 to 2; K represents OR7, NR7R8, R7, etc.; and J and J' represent each hydrogen, halogeno, etc. These derivatives and analogs thereof show an α 4 integlin inhibitory activity and are usable as remedies for various diseases relating to α 4 integlin.
摘要:
L'invention a pour objet de nouveaux dérivés de paraphénylènediamine à groupement pyrrolidinyle substitués par un radical cationique , les compositions tinctoriales les contenant ainsi que le procédé de teinture de fibres kératiniques à partir de ces compositions. La présente invention permet en particulier d'obtenir une coloration de fibres kératiniques chromatiques, puissante, peu sélective et tenace.
摘要翻译:4-吡咯烷子基苯胺衍生物(Ⅰ)是新的。 式(I)的4-吡咯烷子基苯胺衍生物和它们的盐是新的。 N = 0-4; R1 =卤素,Z或1-6C脂肪或脂环烃基,任选地具有由O,N,的Si,S或SO 2代替一个或多个C原子; R2 = Z或-X-C = NR 8-NR 9 R 10(原文如此); X = O或NR11; R8-R11 = H,1-4C烷基或1-4C-羟基烷基; Z =鎓基团。 因此独立权利要求中包括了:(1)氧化性染料组合物,包含一种或多种化合物(I); (2)通过施加在氧化剂的存在下将上述组合物角蛋白纤维的氧化染色; (3)试剂盒,包含氧化染料组合物中的一个隔室,并在氧化另一隔剂如上; (4)式(I“)的硝基化合物。
摘要:
Specified phenylalanine derivatives and analogues thereof have an antagonistic activity to α 4 integrin. They are used as therapeutic agents for various diseases concerning α 4 integrin.
摘要:
The invention is concerned with a process for the manufacture of 3-amino-pyrrolidine derivatives of the formula wherein
R 1 signifies hydrogen, alkyl, cyclo-alkyl, alkenyl, aryl or an amino protecting group; and R 2 , R 3 each independently signify hydrogen, alkyl, cyclo-alkyl, alkenyl or aryl; by converting a compound of the formula wherein
X signifies a protected hydroxy group; in the presence of a primary amine of the formula R 1 NH 2 into the pyrrolidine derivative of the formula wherein X and R 1 have the aforementioned significances; which is subsequently reacted in the presence of R 2 R 3 NH under pressure.
摘要翻译:本发明涉及制备式CHEM的3-氨基 - 吡咯烷衍生物的方法,其中R 1表示氢,烷基,环烷基,烯基,芳基或氨基保护基; R 2,R 3各自独立地表示氢,烷基,环烷基,烯基或芳基; 通过转化式的化合物,其中X表示被保护的羟基; 在式R 1 NH 2的伯胺存在下进入式CHEM的吡咯烷衍生物,其中X和R 1具有上述含义; 其随后在R 2 R 3 NH的存在下在压力下反应。
摘要:
Compounds of formula (I) wherein R1-R5 are independently selected from hydrogen, alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, alkynyl of 2 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 carbon members, aryl, heteroaryl, halogen, -CN, -NO2, -CO2R6, -COR6, -OR6, -SR6, -SOR6, -SO2R6, -CONR7R8, -NR6N(R7R8), -N(R7R8) or W-Y-(CH2)n-Z provided that at least one of R1-R5 is not hydrogen; or R2 and R3 or R3 and R4, taken together form a 3 to 7 membered heterocycloalkyl or 3 to 7 membered heteroaryl; R6 and R7 are independently hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, or aryl; R8 is hydrogen, alkyl of 1 to 6 carbon atoms, perhaloalkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, heterocycloalkyl of 3 to 10 members, aryl or heteroaryl, or R7 and R8, taken together may form a 3 to 7 membered heterocycloalkyl; R9-R12 are independently hydrogen, alkyl of 1 to 4 carbon atoms, perhaloalkyl of 1 to 4 carbon atoms, halogen, alkoxy of 1 to 4 carbon atoms, or cyano, or R9 and R10 or R11 and R12 may be taken together to form aryl of 5 to 7 carbon atoms; G is alkyl of 1 to 6 carbon atoms; X is a bond, -NH, alkyl of 1 to 6 carbon atoms, alkenyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, thioalkyl of 1 to 6 carbon atoms, alkylamino of 1 to 6 carbon atoms, or (CH)J; J is alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or benzyl; and n is an integer from 1 to 6; or pharmaceutical salts thereof, are useful in the treatment of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses-6 and -7, and Kaposi herpesvirus.